Pfizer Covid Vaccine Approved For Emergency Use By US FDA

Malaysia’s deal with Pfizer was on the condition that it received US FDA approval.

Credit: Unsplash and Wikimedia

Subscribe to our Telegram channel for the latest stories and updates.

The Covid-19 vaccine created by Pfizer Inc and BioNTech SE has been approved for emergency use by the U.S. Food and Drug Administration (FDA).

The approval was reportedly the deciding factor as to whether Malaysia would go ahead with its order for the vaccine.

Late last month Malaysia announced that it had signed an agreement with Pfizer for 12.8 million doses of the vaccine to inoculate 6.4 million Malaysians.

That is equal to about 20% of the population.

Prime Minister Tan Sri Muhyiddin Yassin previously said that the vaccine will arrive in stages starting January.

Through this arrangement, Pfizer has agreed to deliver one million doses in the first quarter of next year, followed by 1.7 million doses in the second quarter, 5.8 million in the third quarter and 4.3 million doses in the fourth quarter. Vaccination will be conducted in phases and will prioritise high-risk groups who are more susceptible to Covid-19.
Prime Minister Tan Sri Muhyiddin Yassin via NST

Science, Technology and Innovation Minister Khairy Jamaluddin has said the first million doses will go to frontliners, followed by high risk individuals such as the elderly or those with comorbidities, and then by the rest of the general population.

Health Director-General Tan Sri Dr Noor Hisham has said that the vaccines will be used to those above the age of 18 years old and it will only be given to children under 12 after more research has been done on its side effects.

He was also the one who announced that FDA approval was a requirement for the deal to go ahead.

Share your thoughts with us via TRP’s Facebook, Twitter, and Instagram.